Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin

Br J Cancer. 1999 Jun;80(8):1259-61. doi: 10.1038/sj.bjc.6690494.


The survival of 64 consecutive patients with disseminated midgut carcinoid tumours was compared in a retrospective study with that of 25 consecutive patients with sporadic malignant endocrine pancreatic tumours treated according to similar surgical principles. The presence of hepatic metastases implied a worse prognosis in neuroendocrine tumours of pancreatic rather than midgut origin. This infers that these tumour types must be separated when treatments are evaluated.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Carcinoid Tumor / pathology*
  • Carcinoma, Neuroendocrine / pathology
  • Carcinoma, Neuroendocrine / secondary
  • Female
  • Humans
  • Intestinal Neoplasms / pathology*
  • Liver Neoplasms / secondary*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Pancreatic Neoplasms / pathology*
  • Prognosis
  • Retrospective Studies
  • Survival Analysis